Although these studies differed somewhat in study design, demographic characteristics, and analysis methods, they all found that the association between CRP level and cardiovascular events appeared to be significantly weaker than that with all-cause mortality in patients with T2DM or MetS. Here, CRP is linked to metabolic syndrome.